UBS Group’s Alaunos Therapeutics TCRT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $33.1K | Sell |
6,815
-1,054
| -13% | -$5.11K | ﹤0.01% | 6791 |
|
|
2025
Q1 | $11.6K | Hold |
7,869
| – | – | ﹤0.01% | 7233 |
|
|
2024
Q4 | $15K | Buy |
7,869
+6,841
| +665% | +$13K | ﹤0.01% | 6827 |
|
|
2024
Q3 | $3.31K | Sell |
1,028
-4,457
| -81% | -$14.4K | ﹤0.01% | 7075 |
|
|
2024
Q2 | $38.3K | Buy |
5,485
+3,866
| +239% | +$27K | ﹤0.01% | 5743 |
|
|
2024
Q1 | $29.3K | Buy |
1,619
+591
| +57% | +$10.7K | ﹤0.01% | 5583 |
|
|
2023
Q4 | $10.9K | Sell |
1,028
-717
| -41% | -$7.64K | ﹤0.01% | 6205 |
|
|
2023
Q3 | $34.5K | Buy |
1,745
+80
| +5% | +$1.58K | ﹤0.01% | 5389 |
|
|
2023
Q2 | $127K | Sell |
1,665
-7
| -0.4% | -$536 | ﹤0.01% | 4778 |
|
|
2023
Q1 | $158K | Sell |
1,672
-140
| -8% | -$13.2K | ﹤0.01% | 4523 |
|
|
2022
Q4 | $177K | Sell |
1,812
-112
| -6% | -$10.9K | ﹤0.01% | 4469 |
|
|
2022
Q3 | $496K | Buy |
1,924
+136
| +8% | +$35.1K | ﹤0.01% | 3382 |
|
|
2022
Q2 | $333K | Sell |
1,788
-444
| -20% | -$82.7K | ﹤0.01% | 3625 |
|
|
2022
Q1 | $218K | Sell |
2,232
-4,531
| -67% | -$443K | ﹤0.01% | 4307 |
|
|
2021
Q4 | $1.11M | Buy |
6,763
+1,880
| +39% | +$307K | ﹤0.01% | 3365 |
|
|
2021
Q3 | $1.33M | Buy |
4,883
+2,516
| +106% | +$687K | ﹤0.01% | 3037 |
|
|
2021
Q2 | $938K | Sell |
2,367
-2,411
| -50% | -$955K | ﹤0.01% | 3302 |
|
|
2021
Q1 | $2.58M | Buy |
4,778
+2,074
| +77% | +$1.12M | ﹤0.01% | 2542 |
|
|
2020
Q4 | $1.02M | Sell |
2,704
-267
| -9% | -$101K | ﹤0.01% | 3141 |
|
|
2020
Q3 | $1.12M | Sell |
2,971
-723
| -20% | -$273K | ﹤0.01% | 2845 |
|
|
2020
Q2 | $1.82M | Sell |
3,694
-618
| -14% | -$304K | ﹤0.01% | 2358 |
|
|
2020
Q1 | $1.59M | Sell |
4,312
-288
| -6% | -$106K | ﹤0.01% | 2340 |
|
|
2019
Q4 | $3.26M | Sell |
4,600
-1,704
| -27% | -$1.21M | ﹤0.01% | 2356 |
|
|
2019
Q3 | $4.05M | Buy |
6,304
+2,615
| +71% | +$1.68M | ﹤0.01% | 2016 |
|
|
2019
Q2 | $3.23M | Buy |
3,689
+606
| +20% | +$530K | ﹤0.01% | 2148 |
|
|
2019
Q1 | $1.78M | Sell |
3,083
-1,972
| -39% | -$1.14M | ﹤0.01% | 2503 |
|
|
2018
Q4 | $1.42M | Buy |
5,055
+1,662
| +49% | +$466K | ﹤0.01% | 2722 |
|
|
2018
Q3 | $1.63M | Sell |
3,393
-208
| -6% | -$99.9K | ﹤0.01% | 2758 |
|
|
2018
Q2 | $1.63M | Sell |
3,601
-2,215
| -38% | -$1M | ﹤0.01% | 2694 |
|
|
2018
Q1 | $3.42M | Buy |
5,816
+1,519
| +35% | +$893K | ﹤0.01% | 2144 |
|
|
2017
Q4 | $2.67M | Sell |
4,297
-274
| -6% | -$170K | ﹤0.01% | 2313 |
|
|
2017
Q3 | $4.21M | Buy |
4,571
+168
| +4% | +$155K | ﹤0.01% | 1873 |
|
|
2017
Q2 | $4.11M | Buy |
4,403
+201
| +5% | +$187K | ﹤0.01% | 1842 |
|
|
2017
Q1 | $4M | Sell |
4,202
-1,230
| -23% | -$1.17M | ﹤0.01% | 1796 |
|
|
2016
Q4 | $4.36M | Buy |
5,432
+1,340
| +33% | +$1.08M | ﹤0.01% | 1696 |
|
|
2016
Q3 | $3.46M | Sell |
4,092
-592
| -13% | -$500K | ﹤0.01% | 1831 |
|
|
2016
Q2 | $3.86M | Buy |
4,684
+820
| +21% | +$675K | ﹤0.01% | 1697 |
|
|
2016
Q1 | $4.3M | Sell |
3,864
-2,168
| -36% | -$2.41M | ﹤0.01% | 1568 |
|
|
2015
Q4 | $7.52M | Buy |
6,032
+2,446
| +68% | +$3.05M | ﹤0.01% | 1254 |
|
|
2015
Q3 | $4.85M | Buy |
3,586
+973
| +37% | +$1.31M | ﹤0.01% | 1506 |
|
|
2015
Q2 | $4.7M | Buy |
2,613
+103
| +4% | +$185K | ﹤0.01% | 1663 |
|
|
2015
Q1 | $4.06M | Buy |
2,510
+463
| +23% | +$748K | ﹤0.01% | 1765 |
|
|
2014
Q4 | $1.56M | Buy |
+2,047
| New | +$1.56M | ﹤0.01% | 2421 |
|